Health status and disease severity in fibromyalgia - Results of a six-center longitudinal study

被引:215
作者
Wolfe, F
Anderson, J
Harkness, D
Bennett, RM
Caro, XJ
Goldenberg, DL
Russell, IJ
Yunus, MB
机构
[1] UNIV KANSAS,SCH MED,WICHITA,KS 67214
[2] UNIV OREGON,HLTH SCI CTR,PORTLAND,OR
[3] NORTHRIDGE MED CTR,NORTHRIDGE,CA
[4] UNIV CALIF LOS ANGELES,NORTHRIDGE,CA
[5] NEWTON WELLESLEY HOSP,NEWTON,MA
[6] TUFTS UNIV,NEWTON,MA
[7] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX
[8] UNIV ILLINOIS,COLL MED,PEORIA,IL 61656
来源
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词
D O I
10.1002/art.1780400905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, To determine the intermediate and long-term outcomes of fibromyalgia in patients seen in rheumatology centers in which there is special interest in the syndrome, Methods, We conducted a longitudinal outcome study by mailed comprehensive Health Assessment Questionnaire administered every 6 months to 538 patients, from 6 rheumatology centers, whose median duration of disease at first assessment was 7.8 years, The final assessment took place after 7 years, In addition, there was study followup on 85 patients who had attended the Wichita center for >10 years, Results. Although functional disability worsened slightly and health satisfaction improved slightly, measures of pain, global severity, fatigue, sleep disturbance, anxiety, depression, and health status were markedly abnormal at study initiation and were essentially unchanged over the study period, Correlations between first and last assessment values were as high as r = 0.82, For some variables, abnormalities were 3 times greater at one center compared with another, Conclusion. Patients with established fibromyalgia, seen in rheumatology centers in which there a special interest in the disease and followed up for as long as 7 years, have markedly abnormal scores for pain, functional disability, fatigue, sleep disturbance, and psychological status, and these values do not change substantially over time, Half the patients are dissatisfied with their health, and 59% rate their health as fair or poor, There are marked differences in disease severity among the various centers, but <14% of the variance in outcomes can be explained by demographic or center factors, Values at the first assessment are predictive of final values.
引用
收藏
页码:1571 / 1579
页数:9
相关论文
共 29 条
  • [1] Bengtsson A., 1994, J MUSCULOSKELET PAIN, V2, P67
  • [2] BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728
  • [3] IMMUNOFLUORESCENT DETECTION OF IGG AT THE DERMAL EPIDERMAL JUNCTION IN PATIENTS WITH APPARENT PRIMARY FIBROSITIS SYNDROME
    CARO, XJ
    [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (10): : 1174 - 1179
  • [4] DINERMAN H, 1986, J RHEUMATOL, V13, P368
  • [5] THE NATURAL-HISTORY OF FIBROMYALGIA
    FELSON, DT
    GOLDENBERG, DL
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (12): : 1522 - 1526
  • [6] THE RELATIVE TOXICITY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    FRIES, JF
    WILLIAMS, CA
    RAMEY, D
    BLOCH, DA
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 297 - 306
  • [7] MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS
    FRIES, JF
    SPITZ, P
    KRAINES, RG
    HOLMAN, HR
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (02): : 137 - 145
  • [8] HAWLEY DJ, 1993, J RHEUMATOL, V20, P2025
  • [9] EFFECT OF LIGHT AND SEASON ON PAIN AND DEPRESSION IN SUBJECTS WITH RHEUMATIC DISORDERS
    HAWLEY, DJ
    WOLFE, F
    [J]. PAIN, 1994, 59 (02) : 227 - 234
  • [10] HAWLEY DJ, 1991, J RHEUMATOL, V18, P654